Creatine transporter (CrT; SLC6A8) deficiency (CTD) is an X-linked disorder characterized by severe cognitive deficits, impairments in language and an absence of brain creatine (Cr). In a previous study, we generated floxed Slc6a8 (Slc6a8 flox ) mice to create ubiquitous Slc6a8 knock-
| INTRODUCTION
The absence of the high-energy phosphate buffer creatine (Cr) in the brain leads to intellectual disability (ID), language impairment and epilepsy. 1 There are currently 3 known causes of cerebral Cr deficiency, of which Cr transporter (CrT; SLC6A8) deficiency (CTD)
is the most prevalent. CTD has been estimated to be one of the leading causes of X-linked ID (XLID) in males [2] [3] [4] ; however, little is known about the mechanisms underlying the cognitive deficits. To better understand the underlying patholophysiology of CTD, we generated mice with exons 2 to 4 of the murine Slc6a8 gene flanked with LoxP sites (Slc6a8 flox ). The primary goal in developing this model is to produce a high-fidelity model of CTD that recapitulates as much of the phenotype of human CTD patients as possible.
In our first study, ubiquitous Slc6a8 knockout (Slc6a8 −/y ) mice were derived from Slc6a8 flox mice. 5 Consistent with human CTD, the Slc6a8 −/y mice show an absence of brain Cr and cognitive deficits.
Slc6a8
−/y mice also had reduced body mass and a near absence of Cr in most tissues, including the muscle. 5 The reduction of muscle Cr in Slc6a8 −/y mice may be inconsistent with the limited data from human CTD showing normal muscle Cr levels. 6, 7 Further, the reduced size and loss of muscle Cr could influence the behavioral deficits observed in the Slc6a8 −/y mice, because many of these tasks require physical movement. For example, Slc6a8 −/y mice swam slower than Slc6a8 +/y mice in the Morris water maze (MWM), which may have affected navigating to the hidden platform. 5 This confound could reduce the translational value of this animal. By creating Slc6a8 flox mice, we are able to assess potential confounds using tissue-specific expression of Cre-recombinase.
Using the floxed Slc6a8 (Slc6a8 flox/y ; FLOX) mouse line from Skelton et al's 5 study, Kurosawa et al 8 
created a partial Slc6a8
brain knockout mouse using a Camk2a-cre expressing mouse. The
Camk2a-cre mouse expresses Cre recombinase in excitatory neurons in the forebrain. 9 Similar to the Slc6a8 −/y mice, the Slc6a8 flox/ -Camk2a mice showed spatial learning and novel object deficits. 8 Interestingly, the spatial learning deficits were observed only when the last 3 days of testing were analyzed separately; in comparison Slc6a8 −/y mice showed a robust deficit throughout testing. This would suggest that there could be some motor contribution to the deficit seen in Slc6a8 −/y mice; however, the selection of the Camk2a mouse is somewhat problematic. This is due to Camk2a-cre expression being limited to excitatory neurons in the forebrain;
allowing for the possibility that some Cr-mediated function was spared. The Nestin promoter drives Cre-recombinase expression in neuronal precursor cells, creating a more complete brain-specific knockout. 10 The differences in these Cre-expressing mice are highlighted by a recent study that showed that the offspring from floxed Cc2d1a mice crossed to Nestin-cre mice died at birth while the offspring from floxed mice crossed with Camk2a-cre mice were viable. 11 The use of "Nestin-cre mice" allows for a more complete −/y mice showed MWM deficits during the last 3 days of testing. 12 In a subsequent study, Slc6a8(5-7) flox/y mice were crossed to Nestin-cre mice to create brain-specific knockout mice. These mice show deficits in NOR and Y-maze performance. 13 While this supports the hypothesis that the effects are centrally mediated, the lack of MWM testing in these mice still leaves the possibility that the larger spatial learning deficit seen in Slc6a8(2-4) −/y mice are due to motor deficitsa confound that must be resolved in order to properly model this disorder.
The purpose of this study was to determine if the cognitive deficits seen in the Slc6a8 −/y mice were due to a lack of cerebral Cr by testing brain-specific Slc6a8 knockout (bKO) mice. The behavioral tests used in this study have been shown to be disrupted in Slc6a8 2 | METHODS
| Generation of bKO mice
The bKO mice were generated and maintained on a C57BL/6J background in a pathogen-free facility in microisolators. Female Slc6a8 flox/+ mice, generated and genotyped as described, 5 were mated to mice 
| Locomotor activity
Spontaneous locomotor activity 15 Photocells were spaced 2.5 cm apart. Mice were tested for 1 hour. The dependent measure was total number of photobeams interruptions.
| Morris water maze
The MWM is a test of spatial learning and reference memory 16 ; mice were tested as described. 5 The tank was 122 cm in diameter, white and filled with room temperature (21 C AE 1 C) water. Prior to hidden platform testing, visible platform training (cued) was conducted for 6 days. During this phase, a 10 cm diameter platform with an orange ball mounted above the water on a brass rod was placed in one quadrant. On day 1, mice were given 6 trials with identical start and platform positions as training for the task. Mice were then given 2 trials per day for 5 days with the start and platform positions randomized and curtains closed around the pool to obscure distal cues to assess proximal cue learning.
Hidden platform trials were conducted in 2 phases; each phase consisted of 4 trials per day for 6 days followed by a single probe trial without the platform on day 7. Platform diameters were 10 cm during acquisition and 7 cm during reversal (platform located in the opposite quadrant). Reducing the size of the platform between acquisition and reversal increases the difficulty of the task and may be used to uncover spatial deficits. 16 The trial limit was 90 seconds and the intertrial interval (ITI) was approximately 10 seconds. Mice that failed to find the platform were placed on the platform and given the same 10 seconds ITI. Performance was measured using ANY-maze software (Stoelting Company, Wood Dale, Illinois).
| Novel object recognition
NOR is a test of incidental learning and memory. 17 Mice were tested in the ANY-box apparatus (Stoelting Company). First, mice were habituated to the arena (40 × 40 cm) for 2 days (10 min/d); next they were then habituated to 2 identical objects (10 min/d) for 2 days to reduce neophobia. 18 On the fifth day, mice were presented with 2 new identical objects until 30 seconds of observation time between objects was accrued. One hour later, memory was tested by presenting the mouse with an identical copy of one of the familiar objects along with a novel object. Time exploring an object was defined as entry into a 2 cm zone around the object. Performance was measured using ANY-maze software. A subset of animals (n = 3 from each group) were randomly selected and hand scored to determine if the software accurately tracked the animals. The software-tracked time was highly correlated (r = 0.89, P < .001) with the hand-scored time, suggesting the software accurately tracks the animals. A discrimination index was calculated: time observing the novel object was subtracted from the time observing the familiar object, divided by total object observation time.
| Conditioned fear
Conditioned fear was assessed as described with modification. 19 On day 1, mice were placed in a chamber for 10 minutes before exposure to 3 tone-footshock pairings (82 dB, 2 kHz, 30 seconds on/off cycle).
Each pairing consisted of the 30 seconds tone accompanied during the last second by a scrambled footshock (0.3 mA for 1 second) delivered through the floor. On the second day, mice were returned to the chamber with no tone or shock as a test of contextual fear. On the third day, mice were placed in the chamber with a novel floor. Following 3 minutes of acclimation, the tone was presented for 3 minutes.
On days 2 and 3 freezing behavior was scored. Freezeframe software and Coulbourn test chambers were used (Coulbourn Instruments, Allentown, Pennsylvania). Percent time freezing was analyzed.
| Cr and guanidinoacetic acid determination
Following behavioral testing a subset of mice were sacrificed by decapitation. Brains were divided into hemispheres and flash frozen.
Cr and guanidinoacetic acid (GAA) content were assayed in brain, heart and kidney using a Ultra performance liquid chromatography, tandem mass spectrometry (UPLC-MS/MS) method. 20 First, 20 μL 
| Statistics
Data were analyzed using 1-way analysis of variance (ANOVA) except when there were repeated measurements on the same mouse (interval or day) in which case they were analyzed by repeated-measures ANOVA. Significant effects were analyzed using the method of Benjamini et al. 21 Data were analyzed using GraphPad Prism (La Jolla, CA).
3 | RESULTS 3.2 | Cr and GAA levels
| Body weight

| Brain
There were main effects of gene for Cr (F 3,13 = 39.94, P < .001) and GAA (F 3,13 = 4.3, P < .05) levels ( Figure 1A,B) . Significant reductions in Cr were observed in bKO mice compared with WT, FLOX and Nestin mice. There was a slight reduction in Cr levels in Nestin mice compared with WT mice (P < 0.05) but not in FLOX mice. No differences were observed between FLOX and WT mice. GAA levels were increased in bKO mice compared with the control groups (P < .05).
No differences were observed between control groups for GAA.
| Peripheral tissues
There was no effect of gene on Cr or GAA levels in the heart ( Figure 1C,D) . There was no effect of gene on Cr or GAA levels in the kidney ( Figure 1E,F) . There was no effect of gene on Cr or GAA levels in the muscle or liver (not shown for clarity).
| Locomotor activity
There was a significant main effect of gene (F 3,54 = 21.9; P < .001; 
| Morris water maze
On day 1 cued training, there was trend toward a main effect of gene (F 3,73 = 2.6, P < .07). An increase in latency was seen on days 2 to 6 (main effect of gene: F 3,73 = 6.03, P < .01). No differences were observed between the control groups.
For hidden platform testing, latency and path length were well correlated (r = 0.832, P < .001), therefore, path length is presented to remain consistent with our previous studies. During acquisition, bKO mice had an increased path length compared with control groups (F 3,72 = 13.4, P < .001; all post hoc tests P < .01 vs control groups; Figure 3A ). No differences were observed between control groups.
There were no significant effects of gene on swim speed. During the acquisition probe trial, bKO mice had a greater average distance from the former platform site compared with the WT mice (main effect of gene: F 3,72 = 5.0, P < .001; bKO vs WT P < .05, Figure 3C ). Learning curves for the WT vs bKO mice are shown in Figure 3E .
During reversal, there was a main effect of gene for path length (F 3,69 = 10.2, P < .001; Figure 3B ). bKO mice traveled a longer path to the platform compared with the control groups (P < .05). No differences were observed between control groups. There were no differences in swim speed during reversal. During the reversal probe trial, there was a main effect of gene (F 3,69 = 4.3, P < .01; Figure 3D ). FLOX mice had shorter average distance to the target site compared with WT and bKO mice (P < .05). No other differences were observed.
Learning curves for WT vs bKO mice are shown in Figure 3F .
| Novel object recognition
For time spent observing the novel object, there was a main effect of gene (F 3,56 = 7.7, P < .001; Figure 4 ). Post hoc tests showed that bKO mice spent less time with the novel object compared with control groups (P < .05); the control groups did not differ from each other. No differences were observed in time spent with either object during the familiarization phase (percent time with familiar object that was replaced: control groups = 48.4% AE 2.7%; bKO = 45.6 AE 3.9, P < .6).
| Conditioned fear
On day 1, mice were conditioned to the tone-footshock pairing. On day 2, there was a main effect of gene (F 3,60 = 7.7, P < .01, Figure 4) that was the result of bKO mice spending less time freezing than WT and FLOX mice in the training context (contextual fear). Nestin mice did not show a significant difference from other groups. On day 3, there was a main effect of gene (F 3,64 = 10.3, P < .001, Figure 5 ); bKO mice spent less time freezing to the tone (cued fear) than WT and FLOX mice.
| DISCUSSION
The study was conducted to determine if cognitive deficits observed in ubiquitous Slc6a8 −/y mice were influenced by deficits caused by the Similar to the ubiquitous Slc6a8 −/y mice, bKO mice show learning and memory deficits in the MWM, NOR and conditioned fear, suggesting that these mice have wide-ranging cognitive deficits. This supports the hypothesis that these mice are a high-fidelity model since CTD patients appear to show a global cognitive delay. 1 In contrast to Slc6a8 −/y mice, the MWM deficits appeared without differences in swim speed. Interestingly, the bKO mice had deficits in the cued platform phase, which is a control procedure for swimming performance. However, given a lack of swim speed changes during hidden platform testing, it is unlikely that the cued effect is carrying over to the spatial learning phases of the test. It is also unlikely that the hyperactivity seen in the bKO mice played a role in MWM performance, as land-based hyperactivity does not often translate to increases in exploration in water-based tasks. 16 In addition, female Slc6a8 +/− mice were hyperactive and did not show deficits in NOR or conditioned fear. Further, the data from all models used to date have provided converging evidence of cognitive deficits in both the presence and absence of hyperactivity. Taken together, it is possible but unlikely that the hyperactivity plays a significant role in the cognitive deficits observed.
Attention deficit/hyperactivity disorder has been reported in many CTD patients. 22 Ubiquitous Slc6a8 −/y mice showed initial hypoactivity followed by no difference in an open-field test compared with WT mice. In contrast, bKO mice were hyperactive. In these studies, a photobeam system was used to determine movement. It is possible that the smaller stature of the Slc6a8 −/y mice lead to fewer beam interruptions but the exact cause is unknown. The presence of hyperactivity in these mice represent a new finding in our mice that is present in the CTD population, making the bKO mice a viable model for certain aspects of CTD.
Slc6a8
−/y mice are smaller than Slc6a8 +/y mice which is similar to mice that are deficient in Cr synthesis. 23, 24 The reduction in size is in agreement with human data, as recent case reports show that hypotonia is a phenotype in many CTD patients, 22 suggesting that the FIGURE 5 Contextual and conditioned fear deficits in Slc6a8 bKO mice. bKO mice showed reduced freezing compared with control groups during both the contextual and cued phases of testing. Data are presented as mean AE SEM. **P < .01 vs FLOX and WT used in this study and 2 from the Slc6a8(5-7) flox/y mice. In addition to the bKO mice from this study and the Slc6a8 −/y mice from Skelton et al, 5 Kurosawa et al 8 generated Camk2a-cre::Slc6a8 flox/y mice, creating a forebrain-specific Slc6a8 knockout. 9 These mice showed a reduction in object recognition memory but modest deficits in the MWM that were only seen on when the last 3 days of testing were analyzed separately from the overall ANOVA. In contrast, the learning curves of the WT and bKO mice ( Figure 3E) Cr kinase leads to aberrant neuronal development. 35 In addition, maternal Cr supplementation in rats enhanced hippocampal neuron development and improved long-term potentiation. 36 Taken together, these data suggest that using Nestin-cre mice to generate brainspecific Slc6a8 disruption is more comparable to the ubiquitous Slc6a8 −/y mice.
Baroncelli et al 13 showed that a Nestin-cre-generated brainspecific knockout of exons 5 to 7 of the Slc6a8 gene resulted in NOR and spontaneous alternation deficits. Ubiquitous deletion of the same region results in MWM deficits, but only when the last 3 days of testing were examined separately. 12 Interestingly, this deficit did not fully replicate in a subsequent study when similarly aged mice showed a deficit only on day 5 of testing. 13 This would suggest that both our ubiquitous and our bKO mice have more severe spatial learning deficits than the ubiquitous 5 to 7 deletion. The brain-specific knockout of exons 5 to 7 mice were not evaluated in the MWM. The difference in spatial learning between the 2 Slc6a8 knockouts could also be explained by differences in the test apparatus or procedures; for example, platform to arena size ratio in these studies differ. We used a 144:1 tank-to-platform ratio for the acquisition phase, 5,14 while the Baroncelli studies had a 93.4:1 tank-to-platform ratio. Smaller search ratios simplify the task, 16 perhaps making the lower ratio apparatus less sensitive. Rectifying these differences could provide additional information about this disorder by relating different mutation to known variants in human CTD. This could prove to be difficult as there is a great deal of heterogeneity in CTD-causing mutations.
1
In conclusion, the results of this study show that the cognitive deficits in ubiquitous Slc6a8 −/y mice are attributable to changes in cognitive function and are not caused by being smaller or having motor deficits. Based on this, we suggest that the Slc6a8 −/y mouse is the best model of human CTD. While smaller stature is not always observed in human CTD, all CTD patients have ubiquitous deletion of the gene. Brain-specific models are generated using neuronal precursors that likely allow for the expression of the Slc6a8 gene at the blood brain barrier (BBB). At the BBB, Slc6a8 is expressed in microcapillary endothelial cells and not on astrocytic feet that encompass the majority of the BBB. 37 These cells derive from a mesodermal lineage and any neuronal model of Cre expression would not target them, allowing for Slc6a8 expression at the BBB. Taken together, the bKO data support that, regardless of the model used, ubiquitous Slc6a8 knockout mice are the preferred model of CTD; whereas the bKO models should be limited to studies to provide evidence that the ubiquitous model is not confounded. Therefore, the ubiquitous model should be utilized to develop potential therapeutics for this disorder.
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